Blood Chemistry Testing - Cost Per Reportable Result

Agency: DEPT OF DEFENSE
State: Federal
Type of Government: Federal
FSC Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
NAICS Category:
  • 325413 - In-Vitro Diagnostic Substance Manufacturing
Posted Date: Oct 31, 2025
Due Date:
Solicitation No: W9114F-26-Q-A009
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Blood Chemistry Testing - Cost Per Reportable Result
Active
Contract Opportunity
Notice ID
W9114F-26-Q-A009
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEPT OF THE ARMY
Major Command
US ARMY MEDICAL COMMAND
Office
W40M MRCO EUROPE
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Presolicitation (Original)
  • Original Published Date: Oct 31, 2025 09:13 am EDT
  • Original Response Date:
  • Inactive Policy: Manual
  • Original Inactive Date: Nov 06, 2025
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
  • NAICS Code:
    • 325413 - In-Vitro Diagnostic Substance Manufacturing
  • Place of Performance:
    ITA
Description

The Medical Readiness Contracting Office-Europe intends to issue a solicitation for one (1) automated chemistry analyzer and consumables in support of the laboratory mission at U.S. Army Health Clinic - Vicenza in Vicenza, Italy. The successful offeror shall furnish all equipment, reagents, consumables, controls, and any necessary maintenance to the respective laboratories for the purpose of hematology testing under a Cost Per Reportable Result (CPRR) CLIN structure. All parts, equipment and reagents/consumables shall be supplied and serviced through the Contractor.



The resulting contract will be a Fixed-Price (FFP) Indefinite Delivery/ Indefinite Quantity (IDIQ) contract with a two-month phase in from 02 January 2026 through 28 February 2026 followed by one (1) ordering period from 01 March 2026 to 31 December 2030.



The NAICS code for this solicitation is 324513, In-Vitro Diagnostic Substance Manufacturing with a size standard of 1,250 employees.



Simplified Acquisition Procedures and the Lowest Price Technically Acceptable (LPTA) evaluation process will be used. The solicitation will be issued for full and open competition. A draft of the contract requirements is attached.



A copy of the Request for Quotes will be published on or about 05 November 2025. The RFQ will be posted as a related item to this notice. Interested parties are strongly encouraged to “follow” this notice to receive updates.



All vendors must be registered in the System for Award Management (SAM) prior to response to the solicitation, and lack of registration shall make a quotation ineligible for award. Vendors may obtain information on registration and annual confirmation requirements by calling 1-866-606-8220 or via Internet at https://www.sam.gov.


Attachments/Links
Contact Information
Contracting Office Address
  • MEDICAL READINESS CONTR OFC EUROPE CMR 402
  • APO , AE 09180-0402
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Oct 31, 2025 09:13 am EDTPresolicitation (Original)
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow 6505--Ticagrelor Tablets Active Contract Opportunity Notice ID 36E79726R0028 Related Notice 36E79726R0028 Department/Ind.

VETERANS AFFAIRS, DEPARTMENT OF

Due by 9/17/2026

Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.

DEPT OF DEFENSE

Due by 9/18/2026

Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency

DEPT OF DEFENSE

Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.

DEPT OF DEFENSE

Due by 10/02/2026

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.